Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

583
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
583
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

636
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
636
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

751
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
751
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

626
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
626
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

342
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
342
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

3.1K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in characteristics and outcomes following primary percutaneous coronary intervention: insights from a nationwide analysis.

BMC cardiovascular disorders·2026
Same author

Airway segmentation on CT - A systematic review of machine learning tools.

European journal of radiology open·2026
Same author

AI Integration in Spanish Undergraduate Medical Education: National Cross-Sectional Study.

JMIR medical education·2026
Same author

Randomised Controlled Feasibility Trial of Face-To-Face Diabetes Self-Management Education Shows High Completion Rates Are Needed to Improve Patient-Reported Outcomes.

Diabetes, obesity & metabolism·2026
Same author

Outcomes of percutaneous mechanical aspiration in left-sided infective endocarditis.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Independent Head-to-Head Comparison of Commercial Artificial Intelligence Devices for Lung Cancer Detection on Chest Radiographs.

Radiology·2026
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Related Experiment Video

Updated: Apr 25, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

7.9K

Colchicine for pericarditis.

Samer Alabed1, Juan B Cabello, Greg J Irving

  • 1Continuing Education, University of Oxford, Oxford, UK.

The Cochrane Database of Systematic Reviews
|August 29, 2014
PubMed
Summary
This summary is machine-generated.

Colchicine effectively reduces pericarditis recurrences in patients with acute or recurrent pericarditis when used with NSAIDs. However, evidence is limited, and patients with resistant cases were not studied.

More Related Videos

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.5K
An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.2K

Related Experiment Videos

Last Updated: Apr 25, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

7.9K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.5K
An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.2K

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Trials

Background:

  • Pericarditis is heart inflammation; recurrent pericarditis affects one in three patients.
  • Recurrent pericarditis causes severe chest pain and disability.
  • Colchicine is being investigated for its potential to prevent pericarditis recurrence.

Purpose of the Study:

  • To systematically review randomized controlled trials (RCTs) on colchicine for preventing pericarditis recurrences.
  • To compare colchicine (alone or combined) against other interventions for acute or recurrent pericarditis.

Main Methods:

  • Searched major databases (CENTRAL, MEDLINE, EMBASE) up to August 2014.
  • Included RCTs comparing colchicine to other treatments for pericarditis.
  • Assessed recurrence rates, time to recurrence, symptom relief, and adverse effects.

Main Results:

  • Four RCTs with 564 participants were included.
  • Moderate-quality evidence shows colchicine reduces pericarditis recurrence in recurrent (HR 0.37) and acute (HR 0.40) cases.
  • Colchicine improved symptom relief (RR 1.4) but increased treatment discontinuation due to adverse events (RR 1.87).

Conclusions:

  • Colchicine as adjunctive therapy to NSAIDs effectively reduces pericarditis recurrences.
  • Evidence is based on limited, small trials.
  • Patients with multiple resistant recurrences remain underrepresented in research.